Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISATUXIMAB Cause Chronic obstructive pulmonary disease? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Chronic obstructive pulmonary disease have been filed in association with ISATUXIMAB (Sarclisa). This represents 0.5% of all adverse event reports for ISATUXIMAB.

20
Reports of Chronic obstructive pulmonary disease with ISATUXIMAB
0.5%
of all ISATUXIMAB reports
1
Deaths
20
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From ISATUXIMAB?

Of the 20 reports, 1 (5.0%) resulted in death, 20 (100.0%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISATUXIMAB. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does ISATUXIMAB Cause?

Neutropenia (396) Pneumonia (304) Covid-19 (248) Plasma cell myeloma (241) Thrombocytopenia (227) Infusion related reaction (213) Pyrexia (202) Anaemia (197) Diarrhoea (162) Off label use (126)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which ISATUXIMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

ISATUXIMAB vs ISATUXIMAB-IRFC ISATUXIMAB vs ISAVUCONAZOLE ISATUXIMAB vs ISAVUCONAZONIUM ISATUXIMAB vs ISCALIMAB ISATUXIMAB vs ISENTRESS

Related Pages

ISATUXIMAB Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease ISATUXIMAB Demographics